Sandra E. Nicholson

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease.

A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease.

Journal: Science (New York, N.Y.)

Published: August 27, 2026

The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults.

The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults.

Journal: Vaccine

Published: March 26, 2026

Endosomal escape and cytosolic delivery of cell-penetrating peptide conjugates.

Endosomal escape and cytosolic delivery of cell-penetrating peptide conjugates.

Journal: Bioorganic & medicinal chemistry

Published: March 24, 2026

The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults.

The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults.

Journal: Vaccine

Published: December 14, 2025

ARAP2 regulates responses to interferon-gamma by restricting SOCS1.

ARAP2 regulates responses to interferon-gamma by restricting SOCS1.

Journal: Cell reports

Published: March 12, 2025

Editorial: SOCS: regulation of the immune system at a whole new level.

Editorial: SOCS: regulation of the immune system at a whole new level.

Journal: Frontiers in immunology

Published: March 06, 2025

The Ability of SOCS1 to Cross-Regulate GM-CSF Signaling is Dose Dependent.

The Ability of SOCS1 to Cross-Regulate GM-CSF Signaling is Dose Dependent.

Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

Published: January 09, 2025

Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response.

Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response.

Journal: The Journal of infection

Published: November 24, 2024

The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.

The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.

Journal: The Journal of infection

Published: August 20, 2024

The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old.

The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old.

Journal: The Journal of infection

Published: August 20, 2024

SOCS1 is a critical checkpoint in immune homeostasis, inflammation and tumor immunity.

SOCS1 is a critical checkpoint in immune homeostasis, inflammation and tumor immunity.

Journal: Frontiers in immunology

Published: April 19, 2024

Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunity.

Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunity.

Journal: Nature immunology

Published: December 12, 2023

Showing 1-12 of 72

Last Updated: 09/26/2026